Yalonda Howze's most recent trade in Generation Bio Co was a trade of 25,102 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Generation Bio Co | Yalonda Howze | INTERIM CEO AND PRESIDENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 25,102 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Yalonda Howze | INTERIM CEO AND PRESIDENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 11,883 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Yalonda Howze | INTERIM CEO AND PRESIDENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 10,710 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Yalonda Howze | INTERIM CEO AND PRESIDENT | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Feb 2026 | 7,630 | 0 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Yalonda Howze | INTERIM CEO AND PRESIDENT | 09 Feb 2026 | 3,759 | 0 | - | - | Common Stock | ||
| Generation Bio Co | Yalonda Howze | INTERIM CEO & PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 1,673 | 0 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | INTERIM CEO & PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2026 | 1,673 | 4,254 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | INTERIM CEO & PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. | 02 Feb 2026 | 495 | 3,759 | - | 5.6 | 2,792 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 335 | 1,673 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 335 | 2,680 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. | 15 Jan 2026 | 99 | 2,581 | - | 5.6 | 558 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 334 | 2,444 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 334 | 2,008 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. | 15 Oct 2025 | 99 | 2,345 | - | 6.7 | 664 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 3,347 | 23,427 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 3,347 | 22,084 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 15 Jul 2025 | 983 | 21,101 | - | 0.4 | 419 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 3,347 | 26,774 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 3,347 | 19,720 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 15 Apr 2025 | 983 | 18,737 | - | 0.4 | 362 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,347 | 17,533 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 3,347 | 30,121 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 15 Jan 2025 | 1,160 | 16,373 | - | 0.9 | 1,030 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 251,030 | 251,030 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Howze Yalonda | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 3,347 | 33,468 | - | - | Restricted Stock Units | |
| Generation Bio Co | Howze Yalonda | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.42 per share. | 15 Oct 2024 | 3,347 | 15,169 | - | 2.4 | 8,100 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 15 Oct 2024 | 983 | 14,186 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 3,347 | 12,805 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 3,347 | 36,815 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.93 per share. | 15 Jul 2024 | 983 | 11,822 | - | 2.9 | 2,880 | Common Stock |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 13,388 | 13,388 | - | - | Common Stock | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 13,388 | 40,162 | - | - | Restricted Stock Units | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. | 15 Apr 2024 | 3,930 | 9,458 | - | 3.7 | 14,541 | Common Stock |
| Generation Bio Co | Howze Yalonda | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 118,837 | 118,837 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Howze Yalonda | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 76,310 | 76,310 | - | - | Stock Option (right to buy) | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 107,100 | 107,100 | - | - | Stock Option (Right to Buy) | |
| Generation Bio Co | Yalonda Howze | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 53,550 | 53,550 | - | - | Restricted Stock Units |